Discontinuation report XELODA
| Report ID | 176359 |
| Drug Identification Number | 02238454 |
| Brand name | XELODA |
| Common or Proper name | capecitabine tablets |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CAPECITABINE |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 120 tablets |
| ATC code | L01BC |
| ATC description | ANTIMETABOLITES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2022-11-30 |
| Remaining supply date | 2022-11-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-11-30 | English | Compare |
| v2 | 2022-11-30 | French | Compare |
| v3 | 2022-11-30 | French | Compare |
| v4 | 2022-12-01 | English | Compare |
Showing 1 to 4 of 4